Latest news with #GVP
Yahoo
28-05-2025
- Business
- Yahoo
GVP's Electric Lineworker Scholarship applications due by Sunday
GRAND JUNCTION, Colo. (KREX) — The applications for the CMU Tech Electric Lineworker Scholarship from Grand Valley Power (GVP) are accepted until June 1. The CMU Tech Electric Lineworker Scholarship is a one-time $2,000 scholarship awarded for enrollment in the CMU Tech Electric Lineworker program. Anyone who is a current resident of Mesa County is eligible to apply. Applications can be found at all high school counseling offices, CMU's financial aid webpage under the 'Outside Scholarship Resources' tab or at A committee comprised of electric lineworkers appointed by the management of GVP will review and determine an awardee for the scholarship. The awardee will be notified through their email by July 1. Since 1996, Grand Valley Power has awarded over $299,500 in scholarships to local youth for education and training. For more information about the scholarship program or requirements, individuals can email scholarships@ or call 970-242-0040. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
The Star
28-05-2025
- Business
- The Star
Global venture partners joins forces with Botswana to drive economic growth and media expansion
Staff Reporter | Published 3 hours ago Global Venture Partners (GVP) is excited to announce a landmark strategic partnership with the Botswana Investment and Trade Centre (BITC) that will deliver substantial media value, estimated at about $13 million, to enhance Botswana's global profile. This collaboration will help drive Botswana's economic diversification and elevate the country's standing within the media, tourism, luxury, and sustainability sectors. Through this strategic partnership, GVP intends to establish its African headquarters in Botswana, leveraging its prestigious media brands, Billboard Africa, Rolling Stone MENA, and Robb Report Africa. This partnership is made possible through GVP's collaboration with Penske Media Corporation, ensuring the expansion of Botswana's visibility on a global scale. GVP is based in Dubai, which serves as the hub for global operations. This partnership with Botswana is part of a broader global movement by GVP, with a specific focus on Botswana as a key gateway to Africa. Botswana represents a stable, forward-looking environment that aligns with GVP's vision for long-term, sustainable growth across the continent. Joshua Wilson, Managing Director of GVP, stated, 'GVP is focused on investing across the African continent, with a mass expansion agenda in mind. We are investing in key sectors such as financial services and infrastructure in Rwanda and Ghana, while focusing on expanding the creative sector in South Africa. Our strategy also includes pursuing strategic investments in Ethiopia, Nigeria, Tanzania, and other key jurisdictions to drive growth and innovation across Africa.' Under the leadership of President Advocate Duma Boko, Botswana continues to drive a vision for diversification that positions the country as a model of stability, sustainability, and ethical governance. With its commitment to responsible mineral sourcing, conservation, and prudent economic management, Botswana stands as a beacon of opportunity and growth in Africa, yet it remains underappreciated for its extraordinary accomplishments. Through this collaboration with BITC, GVP is poised to provide tangible value in the following areas: Media Expansion: A substantial media value infusion, using GVP's renowned media brands to promote Botswana as a leading global investment and tourism destination. Infrastructure Development: Supporting Botswana's diversification efforts with key projects in residential and commercial infrastructure, energy, and large-scale arena developments. Banking & Finance: Driving financial innovation and cross-border trade with GVP's banking operations, further enhancing Botswana's financial landscape. Research & Analytics: Expanding research initiatives that will provide actionable insights for investment and development opportunities across Botswana and Africa. As Botswana continues its forward-thinking approach to economic growth and diversification, GVP's African headquarters will serve as the foundation for expanding its brands and commercial operations across the continent. Further quotes from the Government of Botswana and other key stakeholders will follow, underscoring the significance of this transformative strategic partnership. 'We appreciate GVP for recognising the value of locating the headquarters of their African operations in Botswana. ''For Botswana, this partnership holds great significance; it is a first that Botswana will be present in key global media spaces. ''This will amplify our visibility and positioning on the global stage, and we will now have the opportunity to share Botswana's profound story of growth and opportunity, resulting in a significant positive impact on our investment promotion efforts, tourism awareness, and the growth of the creative sector. ''I'm confident that BITC, through the Brand Botswana initiative, will bring together stakeholders to partner and ensure a collective implementation of this partnership for Botswana to derive maximum benefit', Hon Tiroyaone Ntsima, Minister of Trade and Entrepreneurship.
IOL News
27-05-2025
- Business
- IOL News
Global venture partners joins forces with Botswana to drive economic growth and media expansion
Botswana Ambassador to the USA – Mr Mpho Mophuting (Left). Global Venture Partners, Managing Director – Mr Josh Wilson (Right). Image: Supplied Global Venture Partners (GVP) is excited to announce a landmark strategic partnership with the Botswana Investment and Trade Centre (BITC) that will deliver substantial media value, estimated at about $13 million, to enhance Botswana's global profile. This collaboration will help drive Botswana's economic diversification and elevate the country's standing within the media, tourism, luxury, and sustainability sectors. Through this strategic partnership, GVP intends to establish its African headquarters in Botswana, leveraging its prestigious media brands, Billboard Africa, Rolling Stone MENA, and Robb Report Africa. This partnership is made possible through GVP's collaboration with Penske Media Corporation, ensuring the expansion of Botswana's visibility on a global scale. GVP is based in Dubai, which serves as the hub for global operations. This partnership with Botswana is part of a broader global movement by GVP, with a specific focus on Botswana as a key gateway to Africa. Botswana represents a stable, forward-looking environment that aligns with GVP's vision for long-term, sustainable growth across the continent. Joshua Wilson, Managing Director of GVP, stated, 'GVP is focused on investing across the African continent, with a mass expansion agenda in mind. We are investing in key sectors such as financial services and infrastructure in Rwanda and Ghana, while focusing on expanding the creative sector in South Africa. Our strategy also includes pursuing strategic investments in Ethiopia, Nigeria, Tanzania, and other key jurisdictions to drive growth and innovation across Africa.' Under the leadership of President Advocate Duma Boko, Botswana continues to drive a vision for diversification that positions the country as a model of stability, sustainability, and ethical governance. With its commitment to responsible mineral sourcing, conservation, and prudent economic management, Botswana stands as a beacon of opportunity and growth in Africa, yet it remains underappreciated for its extraordinary accomplishments. Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Next Stay Close ✕ Through this collaboration with BITC, GVP is poised to provide tangible value in the following areas: Media Expansion: A substantial media value infusion, using GVP's renowned media brands to promote Botswana as a leading global investment and tourism destination. Infrastructure Development: Supporting Botswana's diversification efforts with key projects in residential and commercial infrastructure, energy, and large-scale arena developments. Banking & Finance: Driving financial innovation and cross-border trade with GVP's banking operations, further enhancing Botswana's financial landscape. Research & Analytics: Expanding research initiatives that will provide actionable insights for investment and development opportunities across Botswana and Africa. As Botswana continues its forward-thinking approach to economic growth and diversification, GVP's African headquarters will serve as the foundation for expanding its brands and commercial operations across the continent. Further quotes from the Government of Botswana and other key stakeholders will follow, underscoring the significance of this transformative strategic partnership. 'We appreciate GVP for recognising the value of locating the headquarters of their African operations in Botswana. ''For Botswana, this partnership holds great significance; it is a first that Botswana will be present in key global media spaces. ''This will amplify our visibility and positioning on the global stage, and we will now have the opportunity to share Botswana's profound story of growth and opportunity, resulting in a significant positive impact on our investment promotion efforts, tourism awareness, and the growth of the creative sector. ''I'm confident that BITC, through the Brand Botswana initiative, will bring together stakeholders to partner and ensure a collective implementation of this partnership for Botswana to derive maximum benefit', Hon Tiroyaone Ntsima, Minister of Trade and Entrepreneurship.
Yahoo
26-05-2025
- Business
- Yahoo
Global Regulatory Requirements for Drug Safety & Pharmacovigilance Certification Program (ONLINE EVENT: May 29, 2025)
Optimize your pharmacovigilance operations with this comprehensive training course tailored for US, EU, and UK standards. Enhance your understanding of product safety compliance, risk assessment, and regulatory reporting to avoid recalls. Learn regulatory frameworks and quality oversight essentials from experienced instructors. Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Global Regulatory Requirements for Drug Safety & Pharmacovigilance Certification Program (ONLINE EVENT: May 29, 2025)" has been added to offering. In today's fast-paced landscape, ensuring comprehensive product safety is paramount for safeguarding a company's reputation and maintaining consumer trust. Companies need to be vigilant about their pharmacovigilance operations to align with evolving US, EU, and UK compliance standards and avoid disruptions in their market presence. Critical to this process is having a thorough understanding of the necessary systems for effective safety reporting and risk assessment. Failure to establish essential processes for safety reporting can result in overlooked issues, leading to significant repercussions, including product recall and non-compliance penalties. Active engagement with international safety standards and regulatory requirements for signaling and risk management remains crucial for sustaining market approval and consumer confidence. Our specialized training course is tailored to guide pharmaceutical and biologic companies in the US and EU through the intricate landscape of product safety regulatory requirements. Participants will gain valuable insights into the strategic decision-making responsible for reporting incidents to regulatory authorities efficiently and effectively. Key Highlights of the Training: An understanding of regulatory requirements for drug safety Overview of US, EU and UK regulatory framework, including details of EU GVP modules and additional requirements for the UK Contents of the PV System Master File (PSMF) Requirements for quality oversight of drug safety Regulations for signal management EU and UK QPPV requirements and responsibilities An engaging and experienced instructor Multiple choice quizzes to test your understanding of the course Who Should Attend: Almost everyone involved in drug development and marketing needs to know the basics of worldwide regulations regarding drug safety. Staff who will benefit include: Drug safety and pharmacovigilance Regulatory affairs Clinical development Executives (including C-Level) with any legal responsibility for drug safety Course Agenda: Global Regulatory Requirements Legalities - US Legalities - EU Penalties for Non-Compliance Matrix of Safety Regulations FDA Regulations FDA Regulation for IND safety reporting IND Annual Report Literature Reporting International Conference on Harmonisation (ICH) ICH Topic Codes and Reports CIOMS Canadian Regulations Key EU Components EU Member States What is Europe? EU, EEA, EFTA EudraVigilance - Pre-Marketing Requirements EudraVigilance - Post-Marketing Requirements EUDRACT EU Clinical Trial Directive EU Clinical Trials Regulation CTIS Qualified Person for Pharmacovigilance (QPPV) requirements Development Safety Update Report European Signaling Regulations EU Pharmacovigilance Legislation Summary of Requirements Penalties and fees GVP modules Quality systems Audit and inspection PV System Master File (PSMF) ADR reporting EU and ex-EU Requirements Internet and Social Media Post-Authorisation Studies Biologics Periodic Safety Update Reports Periodic Benefit-Risk Evaluation Report PSUR Periodicity, ex-EU PSUR Periodicity, EU PSUR (PBRER) New Features PSUR Sections: Detailed Requirements Signal management MAH Responsibilities Signal Detection Signal Validation EudraVigilance Monitoring EudraVigilance Pilot Program UK Regulatory Requirements UK QPPV For more information about this training visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Business
- Yahoo
2 Day Understanding Pharmacovigilance Regulations in Asia Pacific Training Course: Enhance Your PV Strategy with In-Depth Training on RPPV, PSMF, and RMP Requirements (ONLINE EVENT: June 16-17, 2025)
Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Understanding Pharmacovigilance Regulations in APAC Training Course" training has been added to offering. Pharmacovigilance regulations in Asia are dynamic and fast-changing. As the Asia-Pacific region becomes increasingly important for pharmaceutical companies, it's vital to ensure compliance and safety by staying informed of the latest regulatory developments. This two-day pharmacovigilance webinar has been designed to provide a comprehensive guide to compliance in this geographic region. It will provide an ideal opportunity to keep up-to-date with the latest Good Pharmacovigilance Practices (GVP) and post market PV operations in China, and post-market pharmacovigilance regulations in Singapore, Malaysia, the Philippines, and Australia. Our panel of experts from this region will provide an overview of Good Pharmacovigilance Practices and discuss pharmacovigilance-related requirements. Gain key takeaways to better understand the new GVP regulations and pharmacovigilance compliance in these countries. Don't miss this opportunity to learn from industry leaders and enhance your knowledge of dynamic and fast-changing regulations in Asia, and the growing market in the Asia-Pacific region. Benefits of Attending Gain a comprehensive overview of Pharmacovigilance regulations in China, Singapore, Malaysia, the Philippines, and Australia Stay updated with the latest Pharmacovigilance regulations in these countries Enhance your Pharmacovigilance-related knowledge and skills Understand the local requirements for RPPV (QPPV), PSMF, RMP, and other related regulations in each of these countries Certifications: CPD: 6 hours for your records Certificate of completion Who Should Attend: This webinar is intended for anyone involved in and interested in Good Pharmacovigilance Practices (GVP) and the daily practice of pharmacovigilance, including: Professionals working in pharmacovigilance departments Drug safety specialists Adverse reaction monitoring professionals R&D professionals Regulatory affairs specialists Pharmaceutical physicians Key Topics Covered: Day 1 Pharmacovigilance in China - GVP Overview An Overview of China Pharmacovigilance Annual report of China national ADR monitoring China PV concept PV development in China Competent authorities National systems introduction China GVP 2021 Introduction and Requirements Quality management: PV system, quality objective, QA system, QC indicators Organizational structure, personnel, resources: RPPV (QPPV), PV department Monitor and report: data collection, ICSR case processing, report submission, literature search Risk identification and evaluation: incl. PSUR/PBRER, post-marketing safety study Risk control: risk control measures, risk communication, PV plan (RMP) Documentation, record and data management: incl. PSMF PV annual report Brief introduction of clinical PV requirements Best Practices for Compliance with China's GVP Requirements 4 key tips 4 key pitfalls Authority inspection Q&A Post-Market PV Operation PV Operation - Individual Case Study Reports (ICSR) ICSR Overview Adverse Events Collection, Processing, and Submission to Regulatory Authorities National ADR Monitoring System Report Submission Demonstration Periodic Safety Update Report (PSUR)/PBRER Structures and contents Timelines Day 2 Pharmacovigilance Regulations in Singapore, Malaysia, Philippines and Australia Pharmacovigilance Regulations in Malaysia Introduction to Pharmacovigilance in Malaysia and Legal Basis Pharmacovigilance system Responsibilities of MAH, Responsible Person for PV (RPPV), Record Retention Managing ADR/AEFI reports Collection, Validation of reports, ADR reporting systems, Timeframes, and Submission requirements Periodic Benefit-Risk Evaluation (PBRERs) Overview, Format & content of PBRER, Submission requirements, Annexes Risk Management Plans (RMPs) Objective, Structure, Submission requirements, Risk Minimisation activities Pharmacovigilance System Master File (PSMF) Objective, Format & content of PSMF, Annexes Emerging Safety issues, Safety evaluation by NPRA, Safety communications Audits & Inspections Pharmacovigilance Regulations in Singapore Introduction to Pharmacovigilance in Singapore and Legal Basis Responsibilities of the Company Adverse Event reporting Reporting requirements, Records, Special situation reporting Risk Management Plans Submission requirements, Documents, Risk Minimisation activities Periodic Benefit-Risk Evaluation (PBRERs) Reporting requirements Actions taken by Regulatory Authorities Pharmacovigilance Regulations in the Philippines Introduction to Pharmacovigilance in the Philippines and Legal Basis Pharmacovigilance system QPPV Records of PV Reporting of Adverse Reactions Timeframes, Reporting requirements Significant safety Information Risk Management Plan (RMP) Submission requirements, Documents, Risk Minimisation activities Periodic Benefit-Risk Evaluation (PBRERs) Reporting requirements, Format & contents Actions taken by other national drug authorities PV inspections Pharmacovigilance Regulations in Australia Introduction to Pharmacovigilance in Australia Pharmacovigilance system QPPVA and Australian PV contact person APSS (Australian Pharmacovigilance System Summary) DAEN Database Reporting of Adverse Reactions Timeframes, Reporting requirements. Significant safety issues Risk Management Plan (RMP) and Australia Specific Annex (ASA) Submission requirements, Documents, Risk Minimisation activities Periodic Safety Update Reports (PSUR) Reporting requirements, Format & contents Actions taken by other HA's. PV inspections and Pharmacovigilance inspection program (PVIP) Speakers: Raphael Tian Pharmacovigilance Manager Accestra Consulting Mr. Raphael Tian is a seasoned pharmacovigilance Manager at Accestra Consulting, with extensive experience in top global pharmaceutical companies and a focus on the Chinese market. With hands-on experience in Adverse Event monitoring and reporting, Literature screening, Research Related Programs, Market Research and Patient Support Programs, PV agreements, Chinese GVP, and local regulations. Raphael is an experienced trainer in pharmacovigilance with a strong communication network in the local and global pharmaceutical industry in China. Param Dayal Pharma To Market Mr. Param Dayal is a qualified Microbiologist with Master's degree in Microbiology and a certified MedDRA coder. For the last 15 years, Param has worked on a variety of pharmacovigilance projects with special focus on ICSR processing (Unsolicited, solicited, Literature, legal and Clinical trials cases). In his previous roles he worked for organisations supporting pharma clients with PSP program management, PV audits, HA inspections, data migration, SOP Management, process refinement, providing PV training and mentoring to new staff. He also has experience working as a QPPV and Local Safety Officer for Australia and New Zealand. He is currently based in Melbourne working as Drug Safety Manager for Pharma To Market, managing PV activities for NZ clients. Siew Man Phang Pharma To Market Ms. Siew Man Phang is a registered pharmacist in Malaysia, brings over 7 years of pharmacovigilance and regulatory expertise. She has served as QPPV for multinational pharmaceutical, generic, and distributor companies, gaining diverse experience across innovator drugs, generics, biologics, health supplements, traditional products, cosmetic and medical devices. Additionally, she possesses extensive hands-on experience in pharmacovigilance, including adverse event monitoring & reporting, literature & regulatory Intelligence screening, risk management plan, SOP and PSMF writing. She is currently based in Malaysia, works as a Regulatory & Pharmacovigilance Assistant Manager in Pharma To Market handling various pharmaceutical clients, serving as QPPV and managing Pharmacovigilance activities in APAC regions. Marylene Zhan Senior consultant Accestra Consulting Ms. Marylene Zhan is a senior consultant at Accestra Consulting with extensive experience in pharmacovigilance and regulatory affairs, with a Master's Degree from the Zhongnan University of Economics and Law. Marylene is a seasoned bilingual and bicultural consultant who specialises in China regulatory compliance and pharmacovigilance services (RA/PV). She has a wealth of knowledge on Chinese Pharmaceutical regulations and in-depth insight into dealing with Chinese market access requirements. Marylene has a rich experience in serving international pharma companies with market entry into China, providing support in the areas of adverse event monitoring and reporting, literature screening, PV agreements, Chinese GVP and local regulations, SOP & PSMF writing, and more. Helen Ye RA & PV Director Accestra Consulting - Ms. Ye has been dedicated to regulatory affairs consulting for 15 years with a Pharmacy degree from Zhejiang University, China. - She is experienced in regulatory compliance of China market access & post-marketing maintenance of pharmaceutical products, providing insightful and customised solutions to international pharmaceutical companies and government institutions. - She leads the registration team to plan, develop and implement compliance strategies for top pharma clients and has a successful track record for obtaining market approval for drug products, APIs, Excipients, Packaging Materials, medical devices and other products. - Ms. Ye has a strong communication network with Chinese authorities (e.g. NMPA and CDE) and industry experts in China. For more information about this training visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
